NUVL
Nuvalent Inc
NASDAQ: NUVL · HEALTHCARE · BIOTECHNOLOGY
$99.10
-2.79% today
Updated 2026-04-29
Market cap
$8.01B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-5.85
Dividend yield
—
52W range
$64 – $113
Volume
0.6M
Nuvalent Inc (NUVL) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-9.64M | $-14.95M | $-40.00M | $-64.97M | $-99.74M | $-185.06M | $-275.21M |
| Capital expenditures | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | $41000.00 | $729000.00 | $3.55M | $10.32M | $25.56M | $60.58M | $86.50M |
| Free cash flow | $-9.64M | $-14.95M | $-40.00M | $-64.97M | $-99.74M | $-185.06M | $-275.21M |
| Investing cash flow | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | $58.19M | $173.28M | — | — | — |